Sign in

NCT04484675RecruitingPhase 4

Inhaled and Intravenous Milrinone in Patients With Severe Pulmonary Hypertension

Comparative Study Between Inhaled and Intravenous Milrinone in Patients With Severe Pulmonary Hypertension Undergoing Cardiac Surgery

Source: ClinicalTrials.gov · Last updated 30 Apr 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The investigator compared difference between inhaled and intravenous milirinone in patiens with severe pulmonary hypertension undergoing cardiac surgery

Status (registry)
Recruiting
Phase (registry)
Phase 4
Study type
Interventional
Enrollment
38 (estimated)
First submitted
13 Jul 2020
Start date
20 May 2023
Primary completion date
10 May 2025
Lead sponsor
Zagazig University
NCT number
NCT04484675

What you commit to

  • Study type: Interventional · Phase 4
  • Planned participants: 38
  • From 20 May 2023 to the primary completion date, 10 May 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • , coagulopathy, and thromboembolic disease treated with anticoagulants

Lab values

  • Patients were excluded if they had surgery without CPB, preoperative hemodynamic instability (defined as acute requirement for vasoactive support or mechanical device),Patients with severe LV dysfunction (LV ejection fraction of less than 30% congenital heart disease, a contraindication to transesophageal echocardiography (TEE), emergency surgery or re-do surgeries severe renal or hepatic disease

Who the study is looking for

  • Patients scheduled to undergo mitral valve surgery by cardiopulmonary bypass with estimated mean pulmonary artery pressure =\>55 estimated by using preoperative Doppler echocardiography

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Zagazig University
Coordinator of this site? Confirm its status
ZagazigEgyptRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.